Two 59%+ winners, four above 25% in Aug – How this AI model keeps picking winners
Investing.com - Immatics NV reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Immatics NV announced earnings per share of €-0.32 on revenue of €15.06M. Analysts polled by Investing.com EPS of €-0.43 on revenue of €13.83M.
Immatics NV 's are down 24% and is trading at €10.12 , still down 27.71% from its 52 week high of €14.00 set on Thursday, December 23, 2021.
Immatics NV shares lost 1.84% to trade at €10.12 in intra-day trade the report.
Immatics NV follows other major Healthcare sector earnings this month
Immatics NV's report follows an earnings beat by Eli Lilly on Tuesday, November 1, 2022, who reported EPS of €1.98 on revenue of €6.94B, EPS of €1.91 on revenue of €6.91B.
Pfizer had beat expectations on Tuesday, November 1, 2022 with third quarter EPS of €1.78 on revenue of €22.6B, for EPS of €1.44 on revenue of €21.33B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar